Denali Therapeutics Inc. (DNLI): Shares Outstanding
156.18M
As of 2025-12-31
159.76M
As of 2026-06-30
+4.7%
3-year compound annual growth
+5.3%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 156.18M | +8.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 144.22M | +4.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 138.39M | +1.8% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 135.97M | +11.2% | 2024-02-28, Balance as of period end |
| 2021-12-31 | 122.28M | +1.5% | 2023-02-27, Balance as of period end |
| 2020-12-31 | 120.53M | +25.3% | 2022-02-28, Balance as of period end |
| 2019-12-31 | 96.19M | +1.6% | 2021-02-26, Balance as of period end |
| 2018-12-31 | 94.66M | +8.2% | 2020-02-27, Balance as of period end |
| 2017-12-31 | 87.48M | n/a | 2019-03-12, Balance as of period end |